Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Prevent Relapse and Improve the Clinical Course After Hospitalization for Bipolar Depression
Sponsor: Sheppard Pratt Health System
A PHASE2 clinical study on Bipolar Depression, this trial is ongoing. The trial is conducted by Sheppard Pratt Health System and has accumulated 14 data snapshots since 2018. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
14 versions recorded-
May 2025 — Present [monthly]
Unknown PHASE2
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — May 2025 [monthly]
Enrolling By Invitation PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE2
-
May 2023 — Jul 2024 [monthly]
Enrolling By Invitation PHASE2
-
Apr 2022 — May 2023 [monthly]
Enrolling By Invitation PHASE2
▶ Show 9 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Enrolling By Invitation PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2019 — Nov 2020 [monthly]
Enrolling By Invitation PHASE2
Status: Recruiting → Enrolling By Invitation
-
Feb 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sheppard Pratt Health System
For direct contact, visit the study record on ClinicalTrials.gov .